Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences
-
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
-
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
-
Curis to Present at Upcoming Healthcare Conferences in September
-
Sensei Biotherapeutics to Present at Upcoming Conferences
-
Innoviva to Participate in Upcoming Investor Conferences
-
Cantor Fitzgerald Reiterates Overweight Rating on Cipher Mining (CIFR)
-
Zscaler (ZS) PT Lowered to $170 at Cantor Fitzgerald
-
Westwater Resources (WWR) Enters into Exclusivity for $150M Secured Debt Facility
-
Westwater Resources Enters into Exclusivity for $150 million Secured Debt Facility with a Global Financial Institution
-
GitLab Inc (GTLB) PT Raised to $60 at Cantor Fitzgerald
-
SinglePoint Inc. Provides Overview of Round Up Quantity Report from DTCC Detailing the Distribution of Common Stock to Shareholders of Record as of August 15, 2024, to Preserve Round Lot Shareholders
-
Alumis to Participate in Upcoming September Investor Conferences
-
Lexicon Pharmaceuticals to Participate in Upcoming September Investor Conferences
-
Stoke Therapeutics to Present at Upcoming Investor Conferences in September
-
Form N-PX Cantor Fitzgerald Europe For: Jun 30
-
Form N-PX CANTOR FITZGERALD SECURI For: Jun 30
-
Form N-PX CANTOR FITZGERALD, L. For: Jun 30
-
Form N-PX CANTOR FITZGERALD & CO. For: Jun 30
-
Cantor Fitzgerald Reiterates Polestar Automotive (PSNY) at Overweight following CEO change, 'expect delivery volume and margin progression to improve materially in 2H24'
-
3D Systems (DDD) PT Lowered to $3.75 at Cantor Fitzgerald
-
Stratasys Inc. (SSYS) PT Lowered to $12 at Cantor Fitzgerald
-
Form N-PX CANTOR FITZGERALD INFRAS For: Jun 30
-
Cytokinetics to Participate in September Investor Conferences
-
Form NPORT-P CANTOR FITZGERALD INFRAS For: Jun 30
-
Anaptys Announces Participation in September Investor Conferences
-
Polestar shares rebound on funding boost, margins reassure
-
Adagene to Participate in Investor Conferences in September
-
Q32 Bio to Participate in Upcoming September Investor Conferences
-
Iris Energy Ltd. (IREN) PT Lowered to $20 at Cantor Fitzgerald
-
CrowdStrike Holdings (CRWD) PT Lowered to $350 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA), 'Buy on Weakness', 'Remains Our Top Pick'
-
iTeos to Participate in Upcoming Investor Conferences
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
-
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
-
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
-
Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
-
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
-
LeMaitre to Participate at Upcoming Investor Conferences in September
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Remix Therapeutics to Participate in Upcoming Investor Conferences
-
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
-
LifeMD to Participate in Three Investor Conferences During September
-
Trump's Wall Street middleman taps network for potential administration roles
-
Form N-PX CANTOR FITZGERALD INVEST For: Jun 30
-
Zai Lab Announces Participation in September Investor Conferences
-
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
-
aTyr Pharma to Participate in September Investor Conferences
-
DocGo Announces Participation at Four Upcoming Investor Conferences
-
Cantor Fitzgerald Starts MicroStrategy (MSTR) at Overweight

